- Journalists Cover Cyclospora and Measles Outbreaks, and Changing Health Policies
- Update on the SEC’s Work Toward Treasury Clearing Implementation [August 2026]
- Massachusetts behavioral health provider to close after 40+ years
- Why Baylor, Texas Children’s renewed their 73-year affiliation
- Dentsply Sirona posts $898M in Q2 revenue as Return-to-Growth plan progresses
- Justice Department files civil complaint against dental device manufacturer
- The moral injury angle ASC operators haven’t fully reckoned with
- CVS Caremark taps chief growth officer
- Senators press Justice Department to act on Steward CEO contempt case
- Riley Children’s taps physician-in-chief
- The loopholes PE built to buy physicians are starting to crack
- AHMC Healthcare names corporate COO
- 6 competencies, 200 leaders: How a Colorado hospital is rethinking advancement
- As the IPO list disappears, who decides what goes to an ASC?
- Prime Healthcare’s outlook boosted by Fitch
- Medtronic ordered to pay $88M in hernia mesh case
- Saint Francis taps Oklahoma hospital president
- Pediatric dentistry chain seeks state approval $3.8M ASC acquisition
- Pediatric dentistry chain seeks state approval $3.8M ASC acquisition
- 24 state behavioral health policy updates
- Adventist Health, Rady Children’s launch NICU partnership
- 5 highest-paid gastroenterologists in Chicago
- Considering the ASC model? 3 physicians weigh in
- The cardiologist paycheck in 2026: 10 numbers to know
- North Dakota executive order bans kratom
- 5 DSOs making headlines
- Heartland Dental adds 6 offices
- Imagen Dental Partners adds Texas practice
- 5 acquisitions shaking up gastroenterology in 30 days
- Community Behavioral Health Clinics served 3.4 million people in 2025, up 13%
- HCA’s urgent care acquisition spree
- Where GI is booming and where it’s about to run out of physicians
- 60+ House Democrats press VA on mental healthcare staffing gaps
- FDA Reverses Course, Approves First mRNA Flu Shot
- DC opioid settlement funds to cover Medicaid costs
- Massachusetts becomes first state to enforce dental loss ratio standards
- Rebids, resignations and reshuffling: California psych nurse ratios reshape workforce
- Industry Voices—AI won’t fix nurse burnout. Nurses will
- Therapy Dogs Aid Stroke Rehab
- Can Yoga Calm A Grumpy Gut?
- Insurers see positive results in managing health costs in Q2
- Lilly's Zepbound remains physicians' favorite, even as oral obesity launches alter landscape
- UPMC, KLAS Research study examines AI adoption trends, governance barriers
- The AI boom could boost Epic's position, execs say. Here's where AI startups can still win
- Review Finds Little Proof IVF Embryo Transfer Tricks Boost Success
- Short-Term Vegan Diet Linked To Lower Inflammation And Aging
- Novo Nordisk makes Omnicom agency of record for US media buying
- Fresenius Kabi recalls mislabeled morphine lot that could cause overdose death
- Medicaid Work Rule Leaves Homeless People In The Cold
- Wildfire Smoke An Increasing Hazard To U.S. Pregnancies, Study Says
- Budget Battle Erupts in Nation’s Capital Over Opioid Settlement Money
- Watch: Why Abortions Are on the Rise Since ‘Roe’ Was Overturned
- AbbVie’s Skyrizi retakes edge in pharma’s July ad spending league
- 1 in 5 physicians experience depression: Survey
- States battle dental workforce shortages: 4 updates
- VerilyMe, Bausch + Lomb visualize dry eye education in new collaboration
- Arkansas oral surgery practice hit with data breach
- Dentist takes ownership of Pennsylvania dental practice
- Salmonella Outbreak Linked To Imported Jalapeños Sickens Hundreds
- UPDATED: Replimune secures FDA approval for melanoma therapy Tudriqev after long regulatory battle
- UM Health-Sparrow breaks ground on $83M behavioral health facility
- 9 behavioral health layoffs to know | 2026
- Omada Health appoints Wei-Li Shao as new CEO as company ramps up GLP-1 strategy
- New bipartisan 340B reform bill curbs HHS' rebate pilot
- Fierce Pharma Asia—Takeda’s historic narcolepsy nod; Daiichi’s accounting error; Astellas’ revenue beat
- CCBHC model continues to expand, but faces some funding constraints
- Wildfire Smoke Sends More Oregonians To Emergency Rooms
- Weekly Rundown: Hers rolls out new AI-native app; Novo Nordisk, H1 partner on AI-driven clinical development
- Peanut Allergy? Fecal Transplant Might Be A Solution, Pilot Trial Finds
- New CDC Director Dr. Erica Schwartz Takes Over
- Three Midlife Habits That Could Help Protect Your Brain
- Senate committee advances Fauci contempt referral; Schwartz confirmed as new CDC director
- Millie joins UCSF Health's clinically integrated network to coordinate maternity care
- The Interface is the Risk: A MedTech Blueprint for AI and System Integration
- Oscar Health hikes 2026 outlook after record profitability during first half of the year
- Takeda gains FDA nod for first-in-class narcolepsy treatment Orzeyful
- Sarepta’s new CEO Michael Severino faces critical milestones to prove growth
- Germs From Pet Dogs Might Protect Infants Against Infection, Researchers Say
- Want Strong Bones? Review Says Vigorous Sports Like Handball Beat Walking, Strength Training
- Parenting Can Offset ADHD Risk In Toddlers, Study Says
- Nurses Chase Cyclospora, Aided By Interviews, Fast-Food Receipts — And The Messy Details
- Listen to the Latest ‘KFF Health News Minute’
- Watch: Democratic Senator Proposes a Fix for American Healthcare — Covering All Kids
- Medicaid Work Rule Leaves Homeless People in the Cold
- Sanofi asked to change Dupixent ads after Galderma challenge
- Moderna's mRNA flu shot mFlusiva snags FDA nod after refusal-to-file imbroglio
- On the heels of star rating win, Clover Health boosts outlook on strength of MA membership growth in Q2
- Narcan maker Emergent BioSolutions eliminates top R&D role in sweeping restructuring
- ViiV rolls out long-acting HIV campaign targeting ‘future you’
- Fitch: 2025 likely 'a brief operational peak' for nonprofit hospitals ahead of OBBBA changes
- HHS announces decertification of Kentucky-based organ procurement organization Network for Hope
- Autism Therapy Spending Quintuples, Prompting Federal Push For State Oversight
- AstraZeneca, CSPC to form joint venture for biologics manufacturing
- Alcon survey spots gaps in teen eye care ahead of back-to-school season
- Ardent Health offsets Q2 volume stumble by tightening costs, renegotiating contracts
- Could The Air You Breathe Be Triggering Painful Arthritis Flares?
- Childhood Obesity Might Impact Women's Future Ability To Give Birth
- Amwell deepens partnership with Defense Health Agency, boosts 2026 revenue outlook
- AI-Managed Oxygen Promotes More Stable Oxygen Levels In Patients
- Gilead’s HIV PrEP franchise hits $1B quarterly sales, but analysts question Yeztugo durability
- Novo CEO has 'no doubt' on eventual share price recovery as Wegovy pill continues to wow
- Lilly’s obesity pill Foundayo ‘disappointed’ in Q2, as injectables continue to boom
- Maja Pedersen named president, taking reins of Fujifilm's CDMO as CEO role is retired
- ‘No discussions’ ongoing for AstraZeneca-Bristol Myers merger: Reuters
- Type 2 Diabetes Might Make Menopause Worse
- ‘It’s been a roller coaster’: Novo Nordisk’s CFO reflects on ‘pressure’ to drive growth
- AI Is Being Used To Boost Medicaid Enrollment, But Not Without Concerns
- Pesticides Linked To Increased ALS Risk, Review Finds
- Pediatricians and Health Departments Sidestep Trump’s CDC on Vaccine Guidance
- Baltimore Is Rethinking What It Means To Call 911 — And Who Responds
- Closing the gaps in MS care during pregnancy
- CVS enhances supports for patients taking GLP-1s
- Restoring Regulatory Clarity: Statement on Technical Amendments to Rule 0‑1(a)(7)
- Hinge Health to acquire Cylinder Health in a $105M deal to expand into gastrointestinal care
- Women’s ‘new health ecosystem’ takes shape on Reddit: report
- Women’s ‘new health ecosystem’ takes shape on Reddit: report
- Michigan Reports First U.S. Deaths From Parasite Outbreak
- Breathing Exercises Can Curb Addiction Cravings, Review Finds
- Fierce Healthcare Data Breach Tracker: Record-breaking data breach at Unlimited Technology Systems
- Collagen Peptides Show Promise For Women's Bone Health
- As AI use rises, younger adults skip preventive care, survey finds
- Bacterial Vaginosis Tied To Tripled STI Risk, Major Study Finds
- High Body Fat, Not BMI, Linked To Lower Sperm Counts
- New Smart Ring Can Track Blood Sugar, Alcohol
- People With Disabilities Fear Service Cuts As Trump's DOJ Questions Legal Protections
- AI Is Being Used to Boost Medicaid Enrollment, but Not Without Concerns
- Nurses Chase Cyclospora, Aided by Interviews, Fast-Food Receipts — And the Messy Details
- Healthcare Dealmakers—Erlanger joining Prisma, TruBridge acquired and more
- VA Launches Nationwide Trial Of GLP-1 Drug Semaglutide For Problem Drinking
- Premature Menopause Linked To High Blood Pressure
- Beyond the Status Report: Using LLMs to Reveal the True State of SaMD Development
- Transgender 'Top Surgery' Patients Aren't Receiving Adequate Breast Cancer Advice, Researchers Say
- Does Childhood Divorce Increase Kids' Risk Of Adult Depression — Or Is It Other Parental Problems?
- Once-Weekly Pill Could Revolutionize HIV Treatment
- Uninsured But Undaunted, A Surgical Patient Searched The Globe For A Deal
- FTC Sues Hims & Hers Over Health Privacy And Billing Practices
- What Dad Eats Before Conception May Influence Baby's Health
- Family History Plays Role In Genetic Risk For Breast Cancer, Researchers Find
- Daily Routine Key To Good Health, Study Says
- Rising Stars: Publicis CoLab’s Brielle Hoffman is a part of the ‘decision-making that truly affects people’
- Headstands and Summervaults: A Statement on Crypto Vaults and Lending Strategies
- Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Seeking Public Comment on Seeking Public Capital: Remarks Before the Small Business Capital Formation Advisory Committee
- Remarks to the Small Business Capital Formation Advisory Committee
- Statement on Regulation E-Delivery
- Paper Taper: Statement on Proposed Regulation E-Delivery
- Statement on Proposed Regulation E-Delivery
- Remarks before the American-Hellenic Chamber of Commerce
- Remarks at the Society for Corporate Governance Conference
- Insurers propose a median ACA rate hike of 15% for 2027: KFF
Michigan healthcare freedom community forum
The White House withdrew its nomination of Dr. Dave Weldon, a former Florida congressman, shortly before his scheduled appearance before the Senate Health, Education, Labor and Pensions Committee on Thursday. An anonymous White House official has said that Weldon didn't have the votes needed for confirmation by the Senate. Dr. Weldon wrote a four-page statement which was published by The Washington Post and The New York Times.
Big Pharma and the American Public Health Association were opposed to Dr. Weldon because he brought attention to research linking the MMR vaccine and IBD in children.
Jennifer Galardi of the Epoch Times wrote the most complete post mortem of Dr. Weldon's CDC nomination:
https://thefederalist.com/2025/03/14/scuttled-cdc-pick-slams-big-pharma-and-senators-on-its-payroll/
Scuttled CDC Pick Slams Big Pharma And Senators On Its Payroll
By Jennifer Galardi - March 14, 2025In a statement released on the day of his abruptly canceled confirmation hearing, Dr. Dave Weldon, President Trump’s initial nominee to lead the Centers for Disease Control and Prevention, said concerns that Big Pharma was behind the subversion were “probably true.”
“They are hands-down, the most powerful lobby organization in Washington DC giving millions of dollars to politicians on both sides of the aisle,” he wrote.
Weldon said that Wednesday evening, before the morning of his hearing before the Senate Health, Education, Labor, and Pensions (HELP) committee, he had received a call from a White House assistant telling him his nomination had been withdrawn due to a lack of affirmative votes.
According to Weldon’s statement, Health and Human Services Secretary Robert F. Kennedy Jr. told him Sen. Susan Collins of Maine suddenly “had reservations” about confirming him despite having “a very pleasant meeting” with Weldon previously.
“I can assume that the White House staff had my nomination withdrawn also because the Republican Chairman Dr. Bill Cassidy of Louisiana was also voting no,” Weldon wrote.
His claim that “politicians on both sides of the aisle” receive millions of dollars from pharmaceutical companies and lobbyists is undoubtedly true. Pharmaceutical companies spend almost $300 million on lobbying, far outpacing competitors such as the electronics manufacturing industry and insurance companies.
Why might Big Pharma have an interest in pressuring members of Congress to deny Weldon the job? You don’t have to look very far for the answer. Just review the hearings of every health official Trump has nominated to a cabinet position over the past month or so and count how many times “anti-vax” is said.
As a congressman from Florida 25 years ago, Weldon had the “temerity,” as he said in his letter, to question the pharmaceutical companies on what he called two “critical childhood vaccine safety issues.” Weldon said he, like Kennedy, had been approached by hundreds of parents insisting that vaccines had caused injuries, including autism, to their children. Back then, the concern was over a mercury-based preservative in the vaccines known as thimerosal, which is considered a neurotoxin.
Eventually the CDC and pharmaceutical companies agreed to remove thimerosal, though the preservative is still allowed in small amounts in some flu vaccines. The AI overview that pops up in a Google search claims “Extensive scientific research … has concluded that there is no credible evidence linking thimerosal to autism or other neurodevelopmental disorders.” Could it be because the major scientific and medical bodies were incentivized not to find credible evidence?
Weldon asserted that when the “CDC ended up publishing a research study claiming the mercury had done no harm,” there were “credible accusations that CDC had incorrectly manipulated the data to exonerate themselves.”
Weldon also took on the MMR (measles, mumps, rubella) shot, according to his letter, after coming across research by British pediatric gastroenterologist Andrew Wakefield suggesting that many children had suffered a form of inflammatory bowel disease upon taking the MMR shot.
Wakefield sent samples to Irish virologist John O’Leary, “who was able to show … that the inflammatory bowel disease biopsies in these children contained the vaccine strain measles viruses,” Weldon wrote. The theory was that it “also might have been affecting their central nervous system and causing the autistic features.”
Measles cases rose after parents became hesitant to give their kids the MMR shot, due to Wakefield and O’Leary’s research. Essentially, Weldon concluded, O’Leary was pressured to retract his findings and Wakefield lost his medical license.
Weldon believes these two objections killed his shot at being CDC director. He has forever been tarnished as an “anti-vaxxer” despite his insistence that he just wants solid, unbiased research done on the safety of vaccines.
“I have learned the hard way don’t mess with Pharma,” he wrote.
It raises the question: Can Big Pharma be beaten? Can Kennedy and his cohorts at the multiple health agencies really change the way people view health? The entire medical-industrial complex includes not only pharmaceutical companies, but hospitals, insurance companies, and even large food conglomerates, and it propels a good chunk of the American economy.
According to the Census Bureau’s 2019 American Community Survey (ACS), the healthcare industry employs 22 million workers, or 14 percent of the American workforce. Healthcare employment growth is projected to exceed the national average, even though access to primary care physicians is decreasing, suggesting growth in medical bureaucracy and administration rather than direct care providers.
People seem to forget that sickness is a very lucrative business. Pharmaceutical companies, more than any other industry in the medical establishment, are selling you a product. They pressure you to buy — and doctors to sell — their products through commercials, complete with musical dance numbers.
Pharmaceutical companies spend a lot of money researching why people might be hesitant to inject a vaccine into their body, so they can better shut down those concerns. However, according to a report in The Washington Post last week, the NIH will be terminating or limiting grants to fund research related to vaccine hesitancy. It’s a good first step to undoing the propaganda consistently forced down our throats when it comes to so-called healthcare.
Dave Weldon would have been an excellent choice to continue that trend at the CDC. Let’s hope President Trump will find someone equally courageous to follow in his footsteps — someone who can’t be purchased.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.





















